On the benefit of bivalency in peptide ligand/pin1 interactions.

The human peptidyl prolyl cis/trans isomerase (PPIase) Pin1 has a key role in developmental processes and cell proliferation. Pin1 consists of an N-terminal WW domain and a C-terminal catalytic PPIase domain both targeted specifically to Ser(PO(3)H(2))/Thr(PO(3)H(2))-Pro sequences. Here, we report the enhanced affinity originating from bivalent binding of ligands toward Pin1 compared to monovalent binding. We developed composite peptides where an N-terminal segment represents a catalytic site-directed motif and a C-terminal segment exhibits a predominant affinity to the WW domain of Pin1 tethered by polyproline linkers of different chain length. We used NMR shift perturbation experiments to obtain information on the specific interaction of a bivalent ligand to both targeted sites of Pin1. The bivalent ligands allowed a considerable range of thermodynamic investigations using isothermal titration calorimetry and PPIase activity assays. They expressed up to 350-fold improved affinity toward Pin1 in the nanomolar range in comparison to the monovalent peptides. The distance between the two binding motifs was highly relevant for affinity. The optimum in affinity manifested by a linker length of five prolyl residues between active site- and WW domain-directed peptide fragments suggests that the corresponding domains in Pin1 are allowed to adopt preferred spatial arrangement upon ligand binding.

[1]  L. Mayr,et al.  Structural Analysis of the Mitotic Regulator hPin1 in Solution , 2003, Journal of Biological Chemistry.

[2]  S. Esnault,et al.  The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils , 2005, Nature Immunology.

[3]  K. Lu,et al.  Pinning down phosphorylated tau and tauopathies. , 2005, Biochimica et biophysica acta.

[4]  D. Litchfield,et al.  Interactions between Protein Kinase CK2 and Pin1 , 2002, The Journal of Biological Chemistry.

[5]  A. J. Kirby,et al.  Effective Molarities for Intramolecular Reactions , 1980 .

[6]  P. Schimmel,et al.  Conformational energy and configurational statistics of poly-L-proline. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Gemmill,et al.  Vanishingly Low Levels of Ess1 Prolyl-isomerase Activity Are Sufficient for Growth in Saccharomyces cerevisiae* , 2005, Journal of Biological Chemistry.

[8]  P. Carlier,et al.  Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease. , 2004, Current pharmaceutical design.

[9]  R. Huber,et al.  Bivalency as a principle for proteasome inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[11]  K. Lu,et al.  Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism. , 2000, Progress in cell cycle research.

[12]  Bailing Xu,et al.  Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. , 2004, Journal of the American Chemical Society.

[13]  U. Reimer,et al.  Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. , 1998, Biochemistry.

[14]  Tianhua Niu,et al.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.

[15]  W. Atkins,et al.  Novel class of bivalent glutathione S-transferase inhibitors. , 2003, Biochemistry.

[16]  K. Lu Pinning down cell signaling, cancer and Alzheimer's disease. , 2004, Trends in biochemical sciences.

[17]  Tony Hunter,et al.  Structural basis for phosphoserine-proline recognition by group IV WW domains , 2000, Nature Structural Biology.

[18]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[19]  E. Hulme,et al.  Receptor-ligand interactions : a practical approach , 1992 .

[20]  W. Eaton,et al.  Polyproline and the "spectroscopic ruler" revisited with single-molecule fluorescence. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[22]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[23]  M. Kirschner,et al.  Pin1 acts catalytically to promote a conformational change in Cdc25. , 2001, Molecular cell.

[24]  Robert A Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.

[25]  G Fischer,et al.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.

[26]  T. Hunter,et al.  A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.

[27]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[28]  T. Warkentin Bivalent direct thrombin inhibitors: hirudin and bivalirudin. , 2004, Best practice & research. Clinical haematology.

[29]  Miquel Pons,et al.  Peptide Binding Induces Large Scale Changes in Inter-domain Mobility in Human Pin1* , 2003, Journal of Biological Chemistry.

[30]  M. Bowman,et al.  Structural basis for high-affinity peptide inhibition of human Pin1. , 2007, ACS chemical biology.

[31]  Xiao Zhen Zhou,et al.  Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. , 2006, Journal of medicinal chemistry.

[32]  L. Buée,et al.  Regulation of Pin1 peptidyl‐prolyl cis/trans isomerase activity by its WW binding module on a multi‐phosphorylated peptide of Tau protein , 2005, FEBS letters.

[33]  Xiao Zhen Zhou,et al.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules. , 1999, Science.

[34]  A. Means,et al.  The mitotic peptidyl‐prolyl isomerase, Pin1, interacts with Cdc25 and Plx1 , 1998, The EMBO journal.

[35]  Dale F. Mierke,et al.  Receptor–Ligand Interactions , 2004 .

[36]  A. Traish,et al.  The multifunctional nuclear protein p54nrb is multiphosphorylated in mitosis and interacts with the mitotic regulator Pin1. , 2005, Journal of molecular biology.

[37]  D. Lawrence,et al.  Molecular Rulers: An Assessment of Distance and Spatial Relationships of Src Tyrosine Kinase SH2 and Active Site Regions* , 2001, The Journal of Biological Chemistry.

[38]  Xiao Zhen Zhou,et al.  Pin1 modulates the structure and function of human RNA polymerase II. , 2003, Genes & development.

[39]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[40]  Tony Hunter,et al.  Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.

[41]  Masafumi Nakamura,et al.  Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.

[42]  Eric Oldfield,et al.  1H, 13C and 15N chemical shift referencing in biomolecular NMR , 1995, Journal of biomolecular NMR.

[43]  Priti Garg,et al.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis , 2004, The EMBO journal.

[44]  J. Manley,et al.  Pinning Down Transcription: Regulation of RNA Polymerase II Activity During the Cell Cycle , 2004, Cell cycle.

[45]  C. Schiene‐Fischer,et al.  Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1. , 2006, Biochemistry.

[46]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[47]  T. Hsu,et al.  Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis , 2001, Nature Cell Biology.

[48]  K. Fiebig,et al.  Letter to the Editor: 1H, 13C and 15N backbone resonance assignment of the peptidyl-prolyl cis-trans isomerase Pin1 , 2002, Journal of Biomolecular NMR.

[49]  R. Boelens,et al.  Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins. , 1999, Journal of molecular biology.

[50]  W. Jencks,et al.  On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Buée,et al.  1H NMR Study on the Binding of Pin1 Trp-Trp Domain with Phosphothreonine Peptides* , 2001, The Journal of Biological Chemistry.

[52]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[53]  D. Osguthorpe,et al.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.

[54]  S. Murray,et al.  The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response , 2002, Nature.

[55]  M. Schutkowski,et al.  A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates. , 1997, Analytical biochemistry.

[56]  A. Means,et al.  Requirement of the prolyl isomerase Pin1 for the replication checkpoint. , 2000, Science.